WP
DGX icon

Woodline Partners’s Quest Diagnostics DGX Stock Holding History

Woodline Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116M Buy
593,744
+252,372
+74% +$49M 0.44% 36
2025
Q4 		$59.2M Buy
341,372
+223,936
+191% +$40.8M 0.23% 103
2025
Q3 		$22.4M Sell
117,436
-31,037
-21% -$5.51M 0.11% 254
2025
Q2 		$26.7M Sell
148,473
-232,227
-61% -$40.3M 0.14% 220
2025
Q1 		$64.4M Sell
380,700
-123,896
-25% -$20.4M 0.42% 44
2024
Q4 		$76.1M Buy
504,596
+31,535
+7% +$4.9M 0.51% 33
2024
Q3 		$73.4M Sell
473,061
-310,842
-40% -$46.4M 0.62% 29
2024
Q2 		$107M Buy
783,903
+651,672
+493% +$89.2M 1.02% 11
2024
Q1 		$17.6M Buy
+132,231
New +$17.2M 0.16% 189
2022
Q4 		– Sell
-26,408
Closed -$3.24M – 776
2022
Q3 		$3.24M Sell
26,408
-29,425
-53% -$3.88M 0.05% 373
2022
Q2 		$7.42M Buy
+55,833
New +$7.61M 0.11% 208
2020
Q4 		– Sell
-142,339
Closed -$16.3M – 238
2020
Q3 		$16.3M Sell
142,339
-51,505
-27% -$6.09M 0.53% 51
2020
Q2 		$22.1M Buy
+193,844
New +$20.6M 0.88% 43

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Woodline Partners's DGX Position: Q1 2026 in Review

Woodline Partners increased its Quest Diagnostics (DGX) stake by 74% in Q1 2026, buying an estimated $49M and bringing the position to 593,744 shares worth $116M. The position accounts for 0.44% of the portfolio, ranked #36.

Woodline Partners first reported a position in DGX in Q2 2020 and has held it in 13 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Woodline Partners held 593,744 shares of Quest Diagnostics worth $116M as of Q1 2026.
  • Woodline Partners bought 252,372 Quest Diagnostics shares in Q1 2026, an estimated $49M.
  • Quest Diagnostics made up 0.44% of Woodline Partners's portfolio in Q1 2026, its #36 holding.
  • Woodline Partners first reported a position in Quest Diagnostics in Q2 2020 and has held it in 13 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.